CSII - Cardiovascular Systems, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue204,906178,184181,544
Cost of Revenue39,44135,42139,520
Gross Profit165,465142,763142,024
Operating Expenses
Research Development22,91125,93430,977
Selling General and Administrative144,096162,542143,684
Non Recurring-10,36410,364
Total Operating Expenses---
Operating Income or Loss-1,542-56,077-32,637
Income from Continuing Operations
Total Other Income/Expenses Net-164145-71
Earnings Before Interest and Taxes-1,706-55,932-32,708
Interest Expense---
Income Before Tax-1,706-55,932-32,708
Income Tax Expense8692114
Minority Interest---
Net Income From Continuing Ops-1,792-56,024-32,822
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,792-56,024-32,822
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,792-56,024-32,822